Numéro |
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
|
|
---|---|---|
Page(s) | 81 - 86 | |
DOI | https://doi.org/10.1051/medsci/201834f114 | |
Publié en ligne | 7 novembre 2018 |
Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration
Department of Orthopaedics, Zaozhuang Municipal Hospital, 41 Longtou Rd, Zaozhuang 277100, Shandong, P.R. China
* Corresponding author hanslzz@163.com
Osteosarcoma is the most common malignant bone tumor with high incidence in adolescence and poor prognosis. RBM10, a member of RBPs, was reported to be a tumor suppressor in many kinds of cancers. However, the roles of RBM10 in osteosarcoma remain unknown. In this study, we found that overexpression of RBM10 decreased osteosarcoma cell proliferation and colony formation in soft agar, and inhibited osteosarcoma cell migration and invasion. Our results also revealed that RBM10 overexpression induced osteosarcoma cell apoptosis via the inhibition of Bcl-2, the activation of caspase-3, and the transcription and production of TNF-α. Our results indicated that RBM10 acts as a tumor suppressor in osteosarcoma. This could enable to define a new strategy for diagnosis and treatment of patients with osteosarcoma.
Key words: osteosarcoma / RBM10 / tumor suppressor / cell proliferation / cell apoptosis
© 2018 médecine/sciences – Inserm
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.